Healthcare Industry News: ultrasound
News Release - June 14, 2016
Rivanna Medical Prepares for European Market Adoption of Accuro(TM) with the Appointment of New Vice President of Sales (EMEA)Rivanna Medical Announces Receipt of CE Marking, and ISO 13485 Certification
CHARLOTTESVILLE, VA--(Healthcare Sales & Marketing Network) - After recently launching international expansion in the Middle East, Rivanna Medical prepares for European Market adoption of Accuro with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA).
"As Rivanna Medical continues to effectuate global, clinical adoption of Accuro, Andrew Hatton, former Vice President of Sales EMEA for Hologic, joins Rivanna Medical as a key member of the leadership team bringing with him a record of accomplished sales objectives in EMEA," says Rivanna Medical Chairman and CEO Will Mauldin. "This appointment, along with our recent receipt of the CE marking and ISO 13485 certification, is essential for our European and international expansion."
"I am excited to be given the opportunity to introduce the ground breaking product, Accuro, to the EMEA market and to be a key element in Rivanna Medical's international growth strategy," says Andrew Hatton, new Vice President of Sales EMEA.
For anesthesia providers, the affordable, hand-held, and untethered Accuro, by Rivanna Medical, removes the uncertainty of blind-needle guidance. Unlike conventional ultrasound technologies, Accuro is the world's first ultrasound-based system specifically designed to help you apply spinal and epidural anesthesia with automated 3D navigation of the lumbar spine identifying epidural location, depth, and trajectory. Accuro's easy-to-use, innovative technology will improve the efficacy of ultrasound-guided spinal anesthesia helping avoid complications and advance patient outcomes. Certainty can be effortless.
ABOUT RIVANNA MEDICAL
Rivanna Medical, located in Charlottesville, Virginia, is an innovative medical-device company that imagined, engineered, and commercialized the Accuro, the world's first ultrasound-based system specifically designed to help you apply spinal and epidural anesthesia with automated 3D navigation of the lumbar spine identifying epidural location, depth, and trajectory. This proprietary and versatile imaging device is FDA 510(k)-cleared for spinal anesthesia guidance and a variety of additional imaging applications, such as diagnostic imaging of musculoskeletal and abdominal anatomies.
Source: Rivanna Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.